Paul Roche
About Paul Roche
Paul Roche is a Sr. Systems Analyst II, R&D Informatics at Alkermes in Waltham, Massachusetts, with a background in technical and laboratory roles and a Master's degree in Computer Information Systems from Boston University.
Title and Current Position
Paul Roche currently holds the position of Sr. Systems Analyst II in R&D Informatics at Alkermes. He performs his duties in Waltham, Massachusetts, in a hybrid work environment. In this role, he is responsible for maintaining hundreds of R&D applications and managing the migration of informatics systems from acquired businesses, including CDD and Dotmatics.
Professional Experience
Paul Roche has amassed significant experience over the years through various roles in the field of informatics and laboratory sciences. From 2015 to 2018, he worked as a Technical Specialist II at True Health, based in Richmond, VA. From 2012 to 2015, he served as Lead Laboratory Technologist at Health Diagnostic Laboratory, Inc., also in Richmond. Prior to that, he worked as an Analytical Chemist at SGS Accutest from 2010 to 2012 in Marlboro, MA, and as a Laboratory Technician Assistant at Charles River Laboratories for 7 months beginning in 2008 in Shrewsbury, Massachusetts.
Educational Background
Paul Roche has a strong educational background in science and analytics. He obtained a Master of Science (MS) degree in Computer Information Systems with a focus on Data Analytics from Boston University, where he studied from 2017 to 2019. Earlier, he earned a Bachelor of Science (B.S.) in Comprehensive Science from Villanova University, completing his studies there from 2006 to 2010.
Technical Expertise
Paul Roche has developed a range of technical skills throughout his career. He has experience in developing ETL data pipelines, workflows, custom applications, and APIs using technologies such as Python, SQL, R, KNIME, Docker, AWS, ECS, and EC2. Additionally, he has managed offshore DevOps teams to deliver projects using Agile methodologies and gathered detailed requirements from business leaders to support drug discovery initiatives.